MENU
ATXI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Avenue Therapeutics (ATXI) Ownership - Who owns Avenue Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
1111 Kane Concourse
Phone
+1 781 652-4500
Employees
3
Web
https://www.avenuetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.41M
P/E Ratio
0.07
Total Cash
2.6M
Projected Growth
N/A
Total Debt
6.38M
Revenue
N/A
Risk (Beta)
-1.66
Dividend Yield
N/A
Total Cash/Share
1.26
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ATXI
Capitalization
3.41M
P/E Ratio
0.07
Risk (Beta)
-1.66
Dividend Yield
N/A
Total Cash
2.6M
Total Cash/Share
1.26
Total Debt
6.38M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.61M
P/B Ratio
1.31
Cash Flow
N/A
Earnings
24.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
2.70
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-9.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-1169.04
Shares Held By Institutions
457K
Shares Outstanding - Current
2.05M
Total Liabilities
973K
Total Volume MTD
N/A
Value
1
Gain YTD
-86.253
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a pharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Kane Concourse
Phone
+1 781 652-4500
Employees
3
Web
https://www.avenuetx.com